Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2020 Aug 2;8(2):e000186corr1. doi: 10.1136/jitc-2019-000186corr1

Correction: On the mechanism of anti-CD39 immune checkpoint therapy

PMCID: PMC7402001  PMID: 32747468

Allard D, Allard B, Stagg J. On the mechanism of anti-CD39 immune checkpoint therapy. J Immunother Cancer 2020;8:e000186. doi: 10.1136/jitc-2019-000186

In this article, there was an error in the formatting of the P2X receptors in the text. This error has since been corrected.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES